Aldeyra The (ALDX) vs biote Corp. (BTMD)
A side-by-side comparison of Aldeyra The and biote Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.91HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
BTMD
biote Corp.
$1.18HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — ALDX vs BTMD
growth of $100 · dividends reinvested · last 5yALDX -91.3% (-38.6%/yr)BTMD -88.9% (-35.5%/yr)BTMD compounded faster over this window
ALDX BTMD
ALDX vs BTMD: by the numbers
- •ALDX is the larger company ($55M vs $52M market cap).
- •BTMD is profitable (3.19% net margin) while ALDX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ALDX | BTMD |
|---|---|---|
| P/E ratio | N/A | 10.07 |
| P/S ratio | N/A | 0.28 |
| P/B ratio | 1.45 | N/A |
| EV / EBITDA | N/A | 9.10 |
| FCF yield | N/A | 37.97% |
Profitability
| Metric | ALDX | BTMD |
|---|---|---|
| Gross margin | 0.00% | 71.46% |
| Operating margin | 0.00% | 18.50% |
| Net margin | 0.00% | 3.19% |
| ROE | -60.85% | N/A |
| ROIC | -63.52% | 13.63% |
Growth (annualized)
| Metric | ALDX | BTMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.52% |
| EPS CAGR (5Y) | N/A | -25.90% |
| FCF CAGR (5Y) | N/A | 3.81% |
| Total return CAGR (5Y) | -36.54% | -35.12% |
Frequently asked
- Is ALDX or BTMD more profitable?
- BTMD runs the higher net margin — ALDX at 0.00% versus BTMD at 3.19%.
- How have ALDX and BTMD total returns compared?
- Over the past 5 years, ALDX delivered -36.54% and BTMD delivered -35.12% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratioAldeyra The ROEbiote ROEAldeyra The operating marginbiote operating marginAldeyra The revenue growthbiote revenue growthAldeyra The free cash flowbiote free cash flow
Aldeyra The & biote appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.